Fulspec 500 mg Injection can be administered via slow intravenous (IV) infusion over 30-60 minutes or deep intramuscular (IM) injection. For IM, reconstitute with sterile water for injection or 0.9% sodium chloride solution. For IV, dilute further after reconstitution.

The active ingredient in Fulspec 500 mg Injection inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and bacterial death. It possesses a high affinity for key PBPs in susceptible organisms.

• •Known hypersensitivity to the active ingredient or any component of the formulation
• •History of severe hypersensitivity reactions to other beta-lactam antibiotics (e.g., penicillins, other cephalosporins)

Store below 30°C in a dry place, away from light and moisture. Do not freeze. Reconstituted solution should be used immediately or within 6-12 hours if refrigerated.

Overdose may lead to neurological symptoms including convulsions, especially in patients with renal impairment. Treatment is symptomatic and supportive. Hemodialysis may be useful in reducing plasma concentrations.

Pregnancy Category B. Studies in animals have shown no evidence of fetal harm, but adequate and well-controlled studies in pregnant women are lacking. Use during pregnancy only if clearly needed. Excreted in low concentrations into breast milk; caution is advised when administering to a nursing mother.